ApprovalTrail

Approval · Notice of Compliance 34985 · 2025

KALYDECO: Notice of Compliance 34985

Issued March 11, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
34985
Date
March 11, 2025
Company
Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Addition of a drug product manufacturing site and/or manufacturer involving production. Change in the approved design space

Products in this notice

BrandDINStatus today
KALYDECONot yet assigned—

Medicinal ingredients